live
replicationcompet
modifi
vaccinia
viru
tiantan
mvtt
attract
vaccin
vector
yet
littl
known
tissu
tropism
patholog
vivo
recent
demonstr
recombin
mvtt
express
spike
glycoprotein
sarscov
name
mvtt
superior
nonrepl
modifi
vaccinia
ankara
mva
induc
high
level
neutral
antibodi
mucos
vaccin
studi
determin
tissu
tropism
safeti
mvtt
vaccin
administr
variou
rout
includ
intramuscular
im
intranas
intravagin
ivag
inocul
respect
use
realtim
pcr
nest
pcr
immunohistochemistri
situ
hybrid
assay
found
mvtt
abl
produc
transient
infect
case
within
hr
postinocul
yet
major
site
viral
replic
variou
tissu
organ
depend
rout
viral
administr
demonstr
im
inject
mvtt
primarili
target
drain
inguin
lymph
node
wherea
mucos
inocul
broader
rang
tissu
infect
inocul
involv
infect
lung
kidney
spleen
cervix
lymph
node
ivag
administr
target
uterus
ovari
kidney
spleen
critic
infect
caus
sever
pathogen
consequ
infect
tissu
consist
attenu
phenotyp
mvtt
find
implic
optim
vaccin
rout
studi
correl
magnitud
immun
respons
extent
tissu
involv
vivo
mucos
surfac
contain
largest
surfac
area
human
bodi
front
line
natur
defens
variou
pathogen
fact
infecti
diseas
pathogen
human
probabl
gain
entri
host
open
mucos
membran
holmgren
czerkinski
mestecki
exampl
human
immunodefici
viru
type
one
mainli
sexual
transmit
viru
target
primarili
gastrointestin
vagin
mucosa
entri
site
viral
transmiss
viru
replic
amplif
lehner
et
al
miller
et
al
brenchley
douek
shacklett
wu
sinc
establish
initi
replic
mucos
tissu
induct
suffici
mucos
immun
initi
site
transmiss
becom
essenti
protect
vaccin
ohagan
forrest
girard
et
al
hayn
shattock
shattock
et
al
broliden
et
al
demberg
robertguroff
moldoveanu
mestecki
therefor
believ
success
vaccin
abl
elicit
suffici
protect
mucos
immun
pathogen
transmit
via
correspond
mucos
rout
induc
suffici
protect
mucos
immun
necessari
develop
proper
antigen
deliveri
vector
mucos
rout
inocul
variou
deliveri
vector
evalu
purpos
davi
et
al
caley
et
al
fennelli
et
al
pascual
et
al
shata
et
al
stevenson
robert
osorio
et
al
schlereth
et
al
stolteleeb
et
al
kastenmul
et
al
xu
et
al
among
poxvir
vector
probabl
intens
studi
live
recombin
vector
sever
studi
demonstr
abil
induc
mucos
immun
respons
infecti
pathogen
gherardi
et
al
wang
et
al
kent
et
al
particular
vaccin
base
attenu
modifi
vaccinia
viru
ankara
mva
vector
effect
induc
protect
respons
differ
respiratori
virus
sarscov
influenza
respiratori
syncyti
viru
follow
immun
via
mucos
rout
sutter
et
al
degano
et
al
wyatt
et
al
bisht
et
al
olszewska
et
al
de
waal
et
al
chen
et
al
exampl
intranas
inocul
mvabas
vaccin
name
mvahiv
immunogen
wherea
intravagin
rout
disappoint
gherardi
et
al
sinc
mucos
immunogen
mvahiv
low
studi
need
improv
poxviru
vector
system
gherardi
et
al
reason
mvahiv
codeliv
intranas
adjuv
cholera
toxin
ct
significantli
enhanc
cellular
humor
immun
respons
antigen
mucos
surfac
vaccin
mice
due
limit
ct
human
use
vaccinia
vector
system
optim
stimul
mucos
immun
respons
recent
studi
newli
develop
vaccinia
vector
mucos
vaccin
demonstr
replicationcompet
modifi
vaccinia
tiantan
mvtt
express
spike
glycoprotein
sarscov
name
mvtt
superior
nonrepl
modifi
vaccinia
ankara
mva
induc
high
level
neutral
antibodi
mucos
vaccin
huang
et
al
howev
remain
elus
intranas
rout
vaccin
led
significantli
stronger
neutral
antibodi
respons
intramuscular
inject
studi
determin
vivo
tropism
safeti
mvtt
intramuscular
intranas
intravagin
inocul
tri
determin
extent
tissu
involv
support
vaccin
efficaci
find
may
implic
optim
rout
vaccin
studi
correl
magnitud
immun
respons
extent
tissu
involv
vivo
recombin
vaccinia
viru
mvtt
express
gfp
sar
viru
protein
describ
previous
chen
et
al
zhu
et
al
huang
et
al
mvtt
grown
titrat
vero
cell
line
dmem
supplement
fetal
bovin
serum
fb
specif
pathogenfre
femal
bablc
mice
week
old
purchas
center
diseas
control
hubei
provinc
china
anim
studi
protocol
review
approv
institut
anim
care
committe
wuhan
univers
tissu
homogen
deriv
spleen
kidney
lung
uterusovari
collect
hr
postthre
rout
inocul
subject
viral
isol
use
vero
cell
replic
mvtt
test
mous
cell
viral
inoculum
multipl
infect
moi
group
balbc
mice
inocul
intramuscular
im
ml
intranas
ml
intravagin
ivag
ml
rout
mvtt
respect
inoculum
pfu
mvtt
use
vaccin
rout
per
anim
postvaccin
mvtt
placebo
infect
control
anim
sacrif
hr
evalu
acut
infect
day
studi
chronic
outcom
group
contain
three
anim
tissu
specimen
includ
liver
kidney
thymus
heart
lung
spleen
cervix
lymph
node
inguin
lymph
node
uterus
ovari
remov
immedi
anim
sacrif
specifi
time
point
immunohistochemistri
assay
tissu
specimen
fix
immers
sodium
phosphat
buffer
pb
ph
hr
subsequ
embed
paraffin
serial
tissu
section
mm
mount
resinco
microscop
glass
slide
situ
hybrid
assay
tissu
specimen
fix
immers
sodium
phosphat
buffer
ph
embed
paraffin
serial
tissu
section
mm
mount
resinco
microscop
glass
slide
genom
dna
also
isol
kidney
lung
spleen
uterus
ovari
use
standard
protocol
provid
dna
extract
kit
hr
postthre
rout
viral
inocul
whole
blood
sampl
collect
mice
sacrif
serum
sampl
isol
whole
blood
centrifug
rpm
min
poxvir
dna
extract
directli
viral
particl
concentr
ml
serum
use
dna
blood
mini
kit
qiagen
hilden
germani
bp
fragment
vaccinia
viru
gene
amplifi
use
pair
pcr
primer
follow
control
plasmid
construct
use
vector
takara
dalian
china
insert
target
gene
fragment
plasmid
use
gener
standard
curv
amount
viral
dna
properli
quantifi
sybr
green
use
real
time
pcr
pcr
program
sec
follow
sec
cycl
use
biorad
realtim
pcr
cycler
viral
load
repres
number
viral
dna
copi
one
millilit
peripher
blood
tissu
section
first
evalu
hematoxylin
eosin
stain
immunohistochem
assay
mm
thick
tissu
section
deparaffin
rehydr
gradient
xylen
alcohol
pb
section
incub
rabbit
antimvtt
serum
dilut
follow
detect
rabbitsp
stain
kit
zhongshan
beij
accord
manufactur
instruct
situ
hybrid
digoxigeninlabel
probe
sunbio
co
shanghai
china
use
detect
vaccinia
viru
gene
tissu
nonreact
probe
use
control
function
activ
probe
ngml
tissu
section
incub
min
subsequ
cool
ice
min
hybrid
protocol
instruct
manual
situ
hybrid
kit
boster
bio
beij
china
local
posit
cell
captur
ccd
microscop
camera
magnif
blood
sampl
taken
balbc
mice
experiment
inocul
mvtt
intramuscular
im
intranas
intravagin
ivag
inocul
respect
equal
dose
pfu
mvtt
given
anim
serum
viral
load
determin
realtim
pcr
assay
shown
tabl
found
anim
detect
viral
dna
regardless
rout
vaccin
hr
postinfect
averag
level
viral
load
rang
dna
copiesml
blood
acut
phase
infect
im
inject
led
higher
viral
load
compar
ivag
inocul
consist
found
increas
trend
peak
around
hr
postvir
inocul
infect
peripher
blood
mononuclear
cell
pbmc
fac
analysi
fig
averag
im
inject
also
led
infect
mononuclear
cell
infect
howev
appear
transient
anim
viral
dna
detect
hr
postvaccin
tabl
similarli
number
infect
pbmc
also
drop
significantli
hr
postvir
inocul
fig
also
found
mvtt
nonpermiss
induc
plaqu
format
mous
cell
compar
parent
vtt
data
shown
individu
cell
infect
indic
gfp
express
anim
appear
clinic
healthi
without
evid
bodi
weight
loss
sign
sick
address
safeti
issu
inocul
four
chines
macaqu
mvtt
dose
pfu
intranas
rout
four
macaqu
shown
sign
clinic
sick
month
observ
despit
higher
level
viral
load
detect
among
balbc
mice
receiv
im
inject
mvtt
tissu
distribut
viru
rather
limit
cours
infect
use
immunohistochemistri
assay
viral
antigen
primarili
detect
drain
inguin
lymph
node
three
six
mice
around
hr
postinocul
tabl
ii
fig
detect
mvtt
antigen
found
ihc
tissu
includ
spleen
thymu
liver
kidney
lung
heart
uteru
ovari
data
shown
thymu
heart
addit
viral
dna
detect
kidney
hr
spleen
lung
uterusovari
extract
nest
pcr
analysi
live
mvtt
howev
isol
tissu
compart
hr
postvir
inocul
inocul
pfu
mvtt
per
mous
viral
antigen
found
cervic
lymph
node
also
lung
spleen
kidney
tabl
ii
fig
particular
extens
infect
found
lung
three
mice
test
hr
postinfect
lung
present
mous
pneumocyt
express
vacciniaspecif
antigen
fig
moreov
viral
antigen
found
lymph
node
three
mice
test
hr
pi
kidney
three
six
mice
hr
pi
spleen
one
three
mice
hr
pi
endotheli
cell
cortic
tubul
mainli
infect
kidney
fig
interestingli
infect
anim
seem
resolv
infect
quickli
infect
target
tissu
appar
data
repres
three
independ
experi
hr
hour
intranas
inocul
im
intramuscular
inocul
ivag
intavagin
inocul
transient
viru
detect
hr
pi
despit
find
mani
infect
cell
lung
spleen
lymph
node
kidney
signific
pathogen
chang
found
tissu
fig
exampl
sign
lung
damag
despit
detect
signific
amount
viral
antigen
fig
viral
antigen
howev
detect
tissu
test
includ
thymu
liver
heart
uteru
ovari
fig
data
shown
viral
dna
detect
lung
h
spleen
h
kidney
h
uterusovari
extract
nest
pcr
analysi
live
mvtt
also
isol
infect
lung
hr
postvir
inocul
fig
contrast
im
inocul
ivag
rout
target
reproduct
organ
predominantli
shown
figur
larg
amount
infect
cell
found
uterus
ovari
addit
infect
cell
spleen
kidney
endotheli
cell
invagin
uteru
granulos
cell
ovari
infect
earli
detect
mvtt
infect
cell
uterus
five
six
mice
hr
pi
particularli
uniqu
ivag
rout
viral
inocul
moreov
extens
infect
found
ovari
three
mice
test
hr
pi
viral
antigen
also
found
spleen
mice
test
hr
pi
kidney
three
six
mice
hr
pi
note
signific
level
mvtt
infect
ovari
transient
found
three
mice
hr
pi
transient
infect
mvtt
seem
lead
signific
patholog
spleen
kidney
uterus
ovari
mvtt
infect
cell
found
neither
inguin
cervix
lymph
node
viral
dna
detect
lung
h
spleen
hr
kidney
hr
well
uterusovari
hr
extract
nest
pcr
analysi
live
mvtt
mainli
isol
infect
uterusovari
hr
postvir
inocul
fig
unexpectedli
mvtt
antigen
found
two
third
mice
day
postivag
inocul
like
suggest
longer
period
viral
persist
ovari
confirm
distribut
mvtt
infect
cell
tissu
sampl
test
situ
detect
vaccinia
viral
dna
digoxigeninlabel
probe
design
detect
vaccinia
gene
intact
mvtt
found
distribut
posit
cell
consist
immunohistochemistri
stain
shown
figur
posit
cell
readili
detect
tissu
show
viral
antigen
express
posit
cell
type
consist
find
immunohistochem
stain
includ
pneumocyt
lung
endotheli
cell
cortic
tubul
kidney
endotheli
cell
invagin
uterus
granulos
cell
ovari
fig
previou
studi
demonstr
level
anti
neutral
antibodi
correl
protect
pathogen
sarscov
bisht
et
al
other
also
demonstr
mva
less
immunogen
mvtt
induc
suffici
protect
pathogen
sarscov
mous
monkey
model
bisht
et
al
chen
et
al
huang
et
al
investig
mucos
vaccinolog
primari
goal
studi
studi
tissu
tropism
safeti
mvtt
j
med
virol
doi
vaccin
administr
variou
rout
studi
collect
data
mice
studi
vivo
tropism
mvtt
understand
optim
rout
vaccin
correl
magnitud
immun
respons
extent
tissu
involv
vivo
previou
studi
demonstr
much
higher
level
neutral
antibodi
induc
inocul
im
ivag
rout
mice
provid
evid
tissu
distribut
mvtt
quit
differ
distinct
rout
vaccin
appli
also
extent
explain
immunogen
outcom
observ
mvtt
appear
welltoler
vaccin
without
sign
caus
clinic
sick
tissu
patholog
anim
comparison
previou
studi
higher
dose
mvtt
pfu
vs
pfu
use
studi
tri
achiev
robust
viral
infect
vivo
huang
et
al
anim
appear
transient
infect
determin
measur
viral
dna
load
number
infect
peripher
cell
tabl
fig
higher
level
viral
dna
copi
detect
im
infect
mice
anim
infect
mucos
rout
surpris
could
account
better
access
circulatori
system
diffus
alon
despit
detect
viral
dna
infect
cell
experiment
mice
clinic
healthi
without
sign
sick
includ
reduct
bodi
weight
compar
placebo
anim
find
fact
consist
previou
data
mvtt
signific
attenu
j
med
virol
doi
strain
vaccin
huang
et
al
moreov
evalu
pathogen
effect
mvtt
tissu
section
overtim
demonstr
vaccin
strain
caus
sever
patholog
chang
organ
even
signific
viral
infect
fig
similar
conclus
obtain
stain
tissu
section
evalu
veterinari
pathologist
result
like
relat
restrict
replic
capac
mvtt
mous
cell
sinc
mous
genet
distant
human
data
preclud
possibl
mvtt
virul
pathogen
primat
address
issu
four
chines
macaqu
inocul
mvtt
dose
pfu
intranas
rout
shown
sign
clinic
sick
month
observ
therefor
convinc
mvtt
safe
well
toler
sar
vaccin
candid
despit
find
safeti
profil
mvtt
human
still
requir
care
clinic
studi
futur
tissu
tropism
mvtt
despit
induc
similar
level
transient
infect
three
differ
rout
vaccin
ramirez
et
al
previous
demonstr
inocul
mva
target
nasal
associ
lymphoid
tissu
lung
wherea
im
inocul
led
distribut
mva
almost
lymphoid
organ
lung
ovari
ramirez
et
al
studi
although
im
inject
mvtt
result
rel
higher
viral
dna
load
tabl
rang
infect
tissu
appear
limit
compar
ivag
inocul
determin
ihc
nest
pcr
assay
unlik
mva
im
inject
signific
amount
mvtt
antigen
found
drain
lymph
node
fig
wherea
infect
cell
found
tissu
contrast
viral
antigen
found
lung
lymph
node
spleen
kidney
inocul
spleen
kidney
uterus
ovari
ivag
administr
mvtt
also
isol
lung
uterusovari
homogen
ivag
inocul
respect
mucos
deliveri
mvtt
either
ivag
clearli
infect
broader
rang
tissu
organ
sinc
data
base
multipl
anim
tissu
specimen
collect
multipl
time
point
postinfect
like
rout
viral
inocul
determin
vivo
tropism
mvtt
data
also
provid
evid
show
possibl
differ
vaccinia
viral
vector
mvtt
vs
mva
may
distinct
profil
vivo
tropism
find
may
implic
optim
vaccin
rout
studi
correl
magnitud
immun
respons
extent
tissu
involv
vivo
previous
demonstr
inocul
mvtt
superior
im
induc
higher
level
neutral
antibodi
sarscov
huang
et
al
provid
evid
rout
vaccin
led
broader
rang
tissu
involv
includ
lung
lymph
node
spleen
kidney
compar
im
inject
interestingli
although
focal
infect
appear
transient
progress
tissu
involv
especi
respiratori
system
like
contribut
signific
immun
stimul
possibl
explan
probabl
relat
fact
larg
number
antigen
present
cell
resid
lung
associ
lymph
tissu
sertl
et
al
howev
antigen
present
cell
line
mucos
tissu
respiratori
system
would
play
critic
role
immun
stimul
still
requir
investig
although
ivag
inocul
also
result
broader
rang
tissu
infect
spleen
kidney
uterus
ovari
tissu
primari
site
induc
strong
immun
respons
except
spleen
addit
although
mvtt
maintain
replicationcompet
properti
mammalian
cell
time
viral
persist
appear
rather
short
tissu
examin
ovari
contain
detect
virus
hr
postivag
inocul
ivag
show
advantag
induc
better
immun
respons
rout
vaccin
avoid
besid
longterm
consequ
infect
ovari
uterus
remain
unknown
human
